NCT01852643

Brief Summary

Most of the studies performed to compare the present techniques of rhinoplasty have been based on the clinical examination and change of postoperative complaints that cannot be very precise in evaluating the advantages of one technique over another. Therefore, in this study the investigators are going to compare the efficacy of spreader graft and lateral crural overlay techniques by an objective method, rhinomanometry.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Feb 2012

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 9, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 14, 2013

Completed
Last Updated

May 14, 2013

Status Verified

May 1, 2013

Enrollment Period

8 months

First QC Date

May 9, 2013

Last Update Submit

May 13, 2013

Conditions

Keywords

RhinoplastySpreader graft techniqueLateral crural overlay techniqueRhinomanometry

Outcome Measures

Primary Outcomes (2)

  • Nasal flow

    Rhinomanometry is performed by a technician in two stages: before surgery and three months after surgery. It is performed in line with the standards suggested by the "Committee Report on Standardization of Rhinomanometry". After surgery, patients are monitored for one month and rhinomanometry is performed under the same initial conditions after three months. In both stages of rhinomanometry, nasal resistance means are evaluated by Pascal per milliliter per second (Pa/mL/s) and the right and left and total nasal flow indices are evaluated by milliliter per second (mL/s).

    Up to 3 months

  • Nasal resistance

    Rhinomanometry is performed by a technician in two stages: before surgery and three months after surgery. It is performed in line with the standards suggested by the "Committee Report on Standardization of Rhinomanometry". After surgery, patients are monitored for one month and rhinomanometry is performed under the same initial conditions after three months. In both stages of rhinomanometry, nasal resistance means are evaluated by Pascal per milliliter per second (Pa/mL/s) and the right and left and total nasal flow indices are evaluated by milliliter per second (mL/s).

    Up to 3 months

Study Arms (2)

Spreader graft

ACTIVE COMPARATOR
Procedure: Spreader graft

Lateral crural overlay

ACTIVE COMPARATOR
Procedure: Lateral crural overlay

Interventions

Spreader graft technique is performed by a group of expert surgeons.

Spreader graft

Lateral crural overlay technique is performed by a group of expert surgeons.

Lateral crural overlay

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Candidates of rhinoplasty
  • Willingness to participate

You may not qualify if:

  • Having structural problems such as nasal obstruction
  • History of the deformity requiring rhinoplasty of the deviated septum
  • Hardening surgery
  • New clinical conditions or a change in therapeutic technique
  • Unwillingness to continue participating in the study
  • Having no access to subjects after the operation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Plastic Surgery, Alzahra Hospital

Isfahan, Isfahan, Iran

Location

Study Officials

  • Amiryousef Ahmadnia, MD

    Isfahan University of Medical Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

May 9, 2013

First Posted

May 14, 2013

Study Start

February 1, 2012

Primary Completion

October 1, 2012

Study Completion

December 1, 2012

Last Updated

May 14, 2013

Record last verified: 2013-05

Locations